As of 2025-07-09, the Relative Valuation of Bio Rad Laboratories Inc (BIO) is (2,213.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 250.73 USD, the upside of Bio Rad Laboratories Inc based on Relative Valuation is -982.8%.
The range of the Relative Valuation is (2,280.66) - (2,195.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.5x - 31.1x | 29.6x |
| Forward P/E multiples | 26.2x - 28.4x | 27.7x |
| Fair Price | (2,280.66) - (2,195.68) | (2,213.45) |
| Upside | -1009.6% - -975.7% | -982.8% |
| Date | P/E |
| 2025-07-08 | -3.25 |
| 2025-07-07 | -3.20 |
| 2025-07-03 | -3.26 |
| 2025-07-02 | -3.24 |
| 2025-07-01 | -3.21 |
| 2025-06-30 | -3.12 |
| 2025-06-27 | -3.16 |
| 2025-06-26 | -3.15 |
| 2025-06-25 | -3.12 |
| 2025-06-24 | -3.08 |
| 2025-06-23 | -3.05 |
| 2025-06-20 | -3.06 |
| 2025-06-18 | -3.00 |
| 2025-06-17 | -2.98 |
| 2025-06-16 | -3.00 |
| 2025-06-13 | -2.94 |
| 2025-06-12 | -3.01 |
| 2025-06-11 | -2.98 |
| 2025-06-10 | -2.98 |
| 2025-06-09 | -2.92 |
| 2025-06-06 | -2.84 |
| 2025-06-05 | -2.84 |
| 2025-06-04 | -2.87 |
| 2025-06-03 | -2.85 |
| 2025-06-02 | -2.80 |
| 2025-05-30 | -2.94 |
| 2025-05-29 | -2.95 |
| 2025-05-28 | -2.97 |
| 2025-05-27 | -2.98 |
| 2025-05-23 | -2.90 |
| 2025-05-22 | -2.94 |
| 2025-05-21 | -2.95 |
| 2025-05-20 | -3.20 |
| 2025-05-19 | -3.22 |
| 2025-05-16 | -3.22 |
| 2025-05-15 | -3.15 |
| 2025-05-14 | -3.07 |
| 2025-05-13 | -3.28 |
| 2025-05-12 | -3.32 |
| 2025-05-09 | -3.09 |
| 2025-05-08 | -3.12 |
| 2025-05-07 | -3.01 |
| 2025-05-06 | -3.00 |
| 2025-05-05 | -3.11 |
| 2025-05-02 | -3.06 |
| 2025-05-01 | -3.11 |
| 2025-04-30 | -3.16 |
| 2025-04-29 | -3.14 |
| 2025-04-28 | -3.11 |
| 2025-04-25 | -3.14 |